Mainsail Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mainsail Asset Management's BMY Position: Q2 2026 in Review
Mainsail Asset Management increased its Bristol-Myers Squibb (BMY) stake by 91% in Q2 2026, buying an estimated $327K and bringing the position to 11,956 shares worth $726K. The position accounts for 0.28% of the portfolio, ranked #42.
Mainsail Asset Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mainsail Asset Management held 11,956 shares of Bristol-Myers Squibb worth $726K as of Q2 2026.
- Mainsail Asset Management bought 5,687 Bristol-Myers Squibb shares in Q2 2026, an estimated $327K.
- Bristol-Myers Squibb made up 0.28% of Mainsail Asset Management's portfolio in Q2 2026, its #42 holding.
- Mainsail Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mainsail Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.